Mechanistically, the modulation of the Akt/mTOR, Akt/FOXO3a, and AMPK signal pathways are implicated in the mitigation of sarcopenia upon exercise interventions (Figure 7). This evidence concerns the gene FOXO3 and sarcopenia.